Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Phenomenex

Agilent Technologies this week launched the High Sensitivity Protein 250 Kit for the company’s 2100 bioanalyzer. The kit is designed for pharmaceutical QA/QC and life science research applications and detects proteins down to as little as 1 picogram per microliter, which Agilent said is comparable to or better than silver-staining slab gels.
The kit features a dynamic range of four orders of magnitude for quantification and covers a sizing range of 10 to 250 kiloDaltons. Separation, quantitation, and purity measurements can be done in a single step, and typical throughput for QA/QC is 10 samples per hour, Agilent said in a statement. Each kit analyzes up to 100 samples.

Phenomenex introduced the 3 micrometer C18 300 Å HPLC column this week. The C18 reverse phase column is the most efficient of the company’s Jupiter line of products of protein characterization and purification, Phenomenex said in a statement, and provides better resolution and sharper peaks than other phases “enabling the separation of closely eluting proteins.”

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.